Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$10M
1 round on record
Latest round
$10M
Venture round · Nov 2022 · 3 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
47 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 18, 2022 Raised a round Venture round $10M · SEC Form D 2019 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Nov 2022 $10M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity ImmuneSensor Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Qingsong LiExecutive Officer, DirectorSEC Form D
Ernest WongExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Ditto Bio11-50 employees
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.
Boomerang MedicalSeries B $20M · 13 mo ago · 51-200 employees
Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
Valora TherapeuticsVenture round $13M · 2 yr ago · Founded 2023 · 11-50 employees
Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy…
Oblenio BioSeries B $62M · 4 mo ago · 51-200 employees
Oblenio Bio is pursuing broad immune reset as a transformative therapy for refractory autoimmune diseases through our LBL-051 T-cell…
Coultreon BiopharmaSeries A $125M · 6 mo ago · 51-200 employees
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune…
SFA Therapeutics501-1000 employees
SFA Therapeutics is developing a next-generation oral immune tolerance therapy for psoriasis. Our investigational approach is designed to…

Overview

ImmuneSensor Therapeutics | Harnessing the innate immune system to treat inflammation, autoimmune disease and cancer.

People

Qingsong Li
Executive Officer, Director
Ernest Wong
Executive Officer, Director
Ning Zhang
Director
Zhi Hong
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Dallas United States
HQ
ImmuneSensorTherapeutics
50-200 est. staff
Suite 610, Dallas, TX 75235
company site

Financials

Total raised
$10M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $10M Details